Global Med Form 12b-25--10QSB
-----------------------
UNITED STATES OMB APPROVAL
SECURITIES AND EXCHANGE COMMISSION ------------------------
Washington, D.C. 20549 OMB Number: 3235-0058
Expires: January 31, 2002
Estimated average burden
FORM 12b-25 hours per response . 2.50
-------------------------
-------------------------
NOTIFICATION OF LATE FILING SEC FILE NUMBER
0-22083
(Check One): -------------------------
-------------------------
[ ] Form 10-KSB [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR CUSIP NUMBER
37935e-10-1
For Quarter Ended: June 30, 2001 -------------------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: _________________________________________
--------------------------------------------------------------------------------
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
--------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
--------------------------------------------------------------------------------
PART I
REGISTRANT INFORMATION
GLOBAL MED TECHNOLOGIES, INC.
________________________________________________________________________________
Full name of registrant
N/A
________________________________________________________________________________
Former name if applicable
12600 West Colfax, Suite C-420
________________________________________________________________________________
Address of principal executive office (Street and number)
Lakewood, Colorado 80215
________________________________________________________________________________
City, state and zip code
PART II RULE 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
| (a) The reasons described in reasonable detail in Part III of this
| form could not be eliminated without unreasonable effort or
| expense;
|
[X]| (b) The subject annual report, semi-annual report, transition report
| on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will
| be filed on or before the 15th calendar day following the
| prescribed due date; or the subject quarterly report or
| transition report on Form 10-Q, or portion thereof will be filed
| on or before the fifth calendar day following the prescribed due
| date; and
|
| (c) The accountant's statement or other exhibit required by Rule
| 12b-25(c) has been attached if applicable.
PART III
NARRATIVE
State below in reasonable detail why the Form 10-K, 11-K, 20-F 10-Q, N-SAR
or the transition report portion thereof could not be filed within the
prescribed time period. (Attach extra sheets if needed.)
Registrant has encountered delays in completing its Quarterly report
on Form 10-Q for the quarter ended June 30, 2001 because of the transition
to new principal accountants and certain negotiations occurring with
respect to the Company's financing agreements.
PART IV--OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this notification
Michael I. Ruxin (303) 238-2000
--------------------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If answer is no,
identify report(s). [ ] Yes [X] No
----------------------------------------------------------------------------
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion
thereof? [X] Yes [ ] No
If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
For the three months ended June 30, 2001, Registrant incurred a net
loss of approximately $768 thousand on revenues of approximately
$1.531 million. For the three months ended June 30, 2000, registrant
incurred a net loss of $2.097 million on revenues of $1.059 million.
The primary reason for the increase in revenues was increased software
license, maintenance and usage fees. The net loss decreased primarily
because of an increase in revenues of $472 thousand and a decrease in
financing costs of $1.040 million when comparing the three months
ended June 30, 2001 with the comparable prior period.
For the six months ended June 30, 2001, Registrant incurred a net loss
of approximately $1.789 million compared to a net loss of $2.761
million for the six months ended June 30, 2000. For the six months
ended June 30, 2001 and 2000, Registrant recognized revenues of $2.790
million and $1.998 million, respectively. The primary reason for the
decrease in the net loss is the increase in revenues of $792 thousand,
and a decrease in financing costs of $1.062 million, which were
partially offset by higher operating expenses of $758 thousand for the
six months ended June 30, 2001 compared to the similar period in 2000.
================================================================================
GLOBAL MED TECHNOLOGIES, INC.
------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: August 14, 2001 By /s/ Gary L. Cook
-------------------------------------------
Gary L. Cook
Director, Acting Principal Financial
Officer and Treasurer
INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).